StonvexLoading…
StonvexStonvexStonvexCore line items from HUM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.83B | $4.43B | $4.03B | $4.78B |
Operating Income | $2.70B | $2.56B | $4.01B | $3.80B |
Net Income | $1.19B | $1.21B | $2.49B | $2.81B |
EPS (Diluted) | $9.84 | $9.98 | $20.00 | $22.08 |
Total Assets | $48.91B | $46.48B | $47.06B | $43.05B |
Total Liabilities | $31.17B | $30.03B | $30.75B | $27.68B |
Cash & Equivalents | $4.20B | $2.22B | $4.69B | $5.06B |
Free Cash Flow OCF − CapEx | $375.00M | $2.39B | $2.98B | $3.45B |
Shares Outstanding | 120.83M | 120.87M | 124.44M | 127.09M |